BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 32509179)

  • 1. Identification of SOCS family members with prognostic values in human ovarian cancer.
    Yang M; Chen H; Zhou L; Huang X; Su F; Wang P
    Am J Transl Res; 2020; 12(5):1824-1838. PubMed ID: 32509179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the Prognostic Value Among Suppressor Of Cytokine Signaling Family Members in Kidney Renal Clear Cell Carcinoma.
    Li C; Zhang W; Fang T; Li N; Wang Y; He L; He H
    Front Mol Biosci; 2021; 8():585000. PubMed ID: 34926570
    [No Abstract]   [Full Text] [Related]  

  • 3. Comprehensive analysis of suppressor of cytokine signaling proteins in human breast Cancer.
    Sun M; Tang C; Liu J; Jiang W; Yu H; Dong F; Huang C; Rixiati Y
    BMC Cancer; 2021 Jun; 21(1):696. PubMed ID: 34120621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Prognostic Biomarkers Among FAM83 Family Genes in Human Ovarian Cancer Through Bioinformatic Analysis and Experimental Verification.
    Lin S; Du J; Hao J; Luo X; Wu H; Zhang H; Zhao X; Xu L; Wang B
    Cancer Manag Res; 2021; 13():8611-8627. PubMed ID: 34815715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression profiles and prognostic values of BolA family members in ovarian cancer.
    Zhu M; Xiao S
    J Ovarian Res; 2021 Jun; 14(1):75. PubMed ID: 34078439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct expression and prognostic values of GATA transcription factor family in human ovarian cancer.
    Zhou Q; Yang HJ; Zuo MZ; Tao YL
    J Ovarian Res; 2022 Apr; 15(1):49. PubMed ID: 35488350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SOCS proteins and their roles in the development of glioblastoma.
    Dai L; Li Z; Liang W; Hu W; Zhou S; Yang Z; Tao Y; Hou X; Xing Z; Mao J; Shi Z; Wang X
    Oncol Lett; 2022 Jan; 23(1):5. PubMed ID: 34820004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Prognostic Values of the Insulin-Like Growth Factor Binding Protein Family in Ovarian Cancer.
    Zheng R; Chen W; Xia W; Zheng J; Zhou Q
    Biomed Res Int; 2020; 2020():7658782. PubMed ID: 33282953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of the lysyl oxidase family in ovarian cancer.
    Ye M; Zhou J; Gao Y; Pan S; Zhu X
    J Clin Lab Anal; 2020 Dec; 34(12):e23538. PubMed ID: 33058284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive bioinformatics analysis to identify a candidate prognostic biomarker for ovarian cancer.
    Zhu H; Yue H; Xie Y; Du Q; Chen B; Zhou Y; Liu W
    Transl Cancer Res; 2021 Mar; 10(3):1537-1548. PubMed ID: 35116478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annexin A8 can serve as potential prognostic biomarker and therapeutic target for ovarian cancer: based on the comprehensive analysis of Annexins.
    Gou R; Zhu L; Zheng M; Guo Q; Hu Y; Li X; Liu J; Lin B
    J Transl Med; 2019 Sep; 17(1):275. PubMed ID: 31474227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive Analysis of Expression and Prognostic Value of Sirtuins in Ovarian Cancer.
    Sun X; Wang S; Li Q
    Front Genet; 2019; 10():879. PubMed ID: 31572453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct expression and prognostic value of members of the epidermal growth factor receptor family in ovarian cancer.
    Zhou Q; Hou CN; Yang HJ; He Z; Zuo MZ
    Cancer Manag Res; 2018; 10():6937-6948. PubMed ID: 30588099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of key biomarkers associated with development and prognosis in patients with ovarian carcinoma: evidence from bioinformatic analysis.
    Shen J; Yu S; Sun X; Yin M; Fei J; Zhou J
    J Ovarian Res; 2019 Nov; 12(1):110. PubMed ID: 31729978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic values of signal transducers activators of transcription family in ovarian cancer.
    Li S; Sheng B; Zhao M; Shen Q; Zhu H; Zhu X
    Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28536310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments.
    Gao L; Li X; Guo Q; Nie X; Hao Y; Liu Q; Liu J; Zhu L; Yan L; Lin B
    Cancer Cell Int; 2020; 20():509. PubMed ID: 33088217
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Zhou Q; Zhang F; He Z; Zuo MZ
    Front Oncol; 2019; 9():161. PubMed ID: 30967995
    [No Abstract]   [Full Text] [Related]  

  • 18. Expression of SOCS1-7 and CIS mRNA in porcine tissues.
    Delgado-Ortega M; Melo S; Meurens F
    Vet Immunol Immunopathol; 2011 Dec; 144(3-4):493-8. PubMed ID: 21872343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitor of DNA-binding family regulates the prognosis of ovarian cancer.
    Zhou Q; Mei YD; Yang HJ; Tao YL
    Future Oncol; 2021 May; 17(15):1889-1906. PubMed ID: 33728938
    [No Abstract]   [Full Text] [Related]  

  • 20. Knocking off the suppressors of cytokine signaling (SOCS): their roles in mammalian pregnancy.
    Fitzgerald JS; Toth B; Jeschke U; Schleussner E; Markert UR
    J Reprod Immunol; 2009 Dec; 83(1-2):117-23. PubMed ID: 19853926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.